Joscelyne Kerr, a 20-year-old student from Kinross, Scotland, faced a daunting diagnosis of anaplastic pleomorphic xanthoastrocytoma (APXA), a rare form of brain cancer. Initially diagnosed in 2023, she became the first recorded case of this particular cancer in Scotland. Following a high-risk surgery at 18, she underwent chemotherapy and radiotherapy in 2024. Unfortunately, these treatments did not yield the desired results, prompting her to enter a clinical drug trial that has since shown promising outcomes.
The start of this year was filled with uncertainty for Joscelyne, as she feared she might not see another Christmas. However, a recent scan brought life-changing news: the trial drugs had effectively eradicated her tumour. This development has not only inspired her but also motivated her to raise awareness for the Brain Tumour Research Christmas Appeal, which seeks to fund innovative research.
Joscelyne reflected on her journey, stating, “It was such an unbelievable thing to hear as we never expected the crystallised core of Pedro to be dissolved by the drugs.” She expressed the difficulty in fully embracing good news, as the fear of potential setbacks lingers. “This whole experience makes me scared to believe that any good news about my prognosis is really good news,” she admitted. Yet, she remains optimistic, drawing strength from her family and friends.
While a small speck appeared on her most recent scan, suggesting the possibility of either a new tumour or a stressed nerve, Joscelyne continues to live her life with zeal. Now in her third year studying astrophysics at the University of Edinburgh, she stated, “I try to protect myself mentally and focus on enjoying life until I’m told otherwise.” She emphasised the importance of maintaining a positive outlook despite the challenges she faces.
Joscelyne is excited to celebrate Christmas with her family this year. She recalled last year’s memorable time spent in New Zealand with relatives and is looking forward to returning to her family’s traditional holiday activities, including gingerbread competitions and long dog walks. “It’s all about being with the ones you love,” she said.
Her commitment to the cause is evident as she aims to raise funds and awareness for brain tumours, which can affect individuals of any age and are responsible for more deaths in those under 40 than any other cancer. Alarmingly, only one per cent of the national cancer research budget has been allocated to brain tumours since 2002. “If I can make a difference and raise awareness for everyone out there who deserves to be heard and seen, then I feel honoured to be one of the faces for the charity’s Christmas appeal,” Joscelyne added.
Through her advocacy and resilience, Joscelyne Kerr is not only celebrating another Christmas but also shining a light on the urgent need for research into brain cancer. Her journey underscores the importance of support, hope, and the power of community in the fight against this devastating disease.
